Kepos Capital LP Natera, Inc. Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$17.27 - $40.17 $61,947 - $144,089	-3,587 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$25.38 - $34.89 $421,079 - $578,859	-16,591 Reduced 82.22%	3,587 $118,000
Q2 2019 Aug 13, 2019	SELL	$17.75 - $27.58 $252,103 - $391,718	-14,203 Reduced 41.31%	20,178 $557,000
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $647,050 - $995,673	34,381 New	34,381 $823,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.